1. Academic Validation
  2. A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo

A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo

  • Cell Res. 2017 Mar;27(3):440-443. doi: 10.1038/cr.2017.16.
Chao Jiang 1 Miao Mei 1 Bin Li 2 Xiurui Zhu 3 Wenhong Zu 1 Yujie Tian 1 Qiannan Wang 1 Yong Guo 3 Yizhou Dong 2 Xu Tan 1
Affiliations

Affiliations

  • 1 School of Pharmaceutical Sciences, Center for Infectious Disease Research, School of Medicine, Tsinghua University, Tsinghua-Peking Center for Life Sciences, Beijing 100084, China.
  • 2 Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
  • 3 Department of Biomedical Engineering, School of Medicine, Tsinghua University, Beijing 100084, China.
Figures
Products